View of RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE STUDIES OF SODIUM-GLUCOSE CO-TRANSPORTER 2 (SGLT2) AND DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS EMPAGLIFLOZIN AND LINAGLIPTIN IN PHARMACEUTICAL DOSAGE FORM.

Return to Article Details RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE STUDIES OF SODIUM-GLUCOSE CO-TRANSPORTER 2 (SGLT2) AND DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS EMPAGLIFLOZIN AND LINAGLIPTIN IN PHARMACEUTICAL DOSAGE FORM. Download Download PDF